Johnson & Johnson (JNJ) Net Income towards Common Stockholders (2009 - 2026)

Johnson & Johnson has reported Net Income towards Common Stockholders for 17 years, with the latest figure at $5.5 billion in Q2 2026.

• Quarterly Net Income towards Common Stockholders changed 0.05% year-over-year to $5.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.0 billion (up 27.22% YoY) and the FY2023 annual result came in at $21.8 billion, up 1289.37% from the prior year.
• Net Income towards Common Stockholders advanced to $5.5 billion in Q2 2026 per JNJ's latest filing, from $5.2 billion in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $21.7 billion in Q4 2023 and troughed at -$232.0 million in Q3 2023.
• A 4-year average of $4.4 billion and a median of $2.8 billion in 2022 frame the typical range for Net Income towards Common Stockholders.
• The widest YoY moves for Net Income towards Common Stockholders: up 14575.0% in 2023, down 142.03% in 2023.
• Over 4 years, Net Income towards Common Stockholders stood at $148.0 million in 2022, then plunged by 156.08% to -$83.0 million in 2023, then soared by 6263.86% to $5.1 billion in 2025, then gained by 8.17% to $5.5 billion in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $5.5 billion, $5.2 billion, and $5.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.